Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold Depression

Sponsor
Forschungsinstitut der Diabetes Akademie Mergentheim (Other)
Overall Status
Completed
CT.gov ID
NCT01009138
Collaborator
German Diabetes Center (Other), University of Giessen (Other), Heinrich-Heine University, Duesseldorf (Other)
214
1
2
30
7.1

Study Details

Study Description

Brief Summary

This work is supported by the "Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)" funded by the Federal Ministry of Education and Research (FKZ 01GI0809).

Approximately one third of diabetic patients has elevated depressive symptoms. The majority of these patients are suffering from a subthreshold depression. In spite of the fact that subthreshold depression has an equivalent negative impact on the prognosis of diabetes as clinical depression, there is no specific intervention tool. The main objective of this project is to develop a diabetes specific cognitive behavioural treatment (DS-CBT) for diabetic patients with subthreshold depression. In a randomized trail DS-CBT is compared to standard diabetes education. A total of 188 diabetic patients will be recruited and randomly assigned to the two treatment conditions. The expected main outcome is the reduction of subthreshold depression under DS-CBT in a 12 month follow up. Secondary variables are improvement of glycaemic control, quality of life, diabetes self-management as well as reduction of health care costs and modification of inflammatory parameters.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Diabetes-Specific CBT (DS-CBT)
  • Behavioral: Standard Diabetes Education
N/A

Detailed Description

Elevated rates for depression in diabetic patients are of clinical significance for diabetology. Depressive disorders are doubled compared to patients without diabetes. A meta-analysis showed that a proportion of 20% of diabetic patients showed subthreshold depression, defined as elevated depressive symptoms without meeting criteria for clinical depression. Depression in diabetes is associated with a reduced quality of life, more diabetes related distress, and higher health related costs. But besides this, depression in diabetes seems to be an independent negative prognostic factor for morbidity and mortality. Furthermore subthreshold depression is a major barrier of an effective self-management of the disease.

Until now antidepressive therapies are only evaluated in clinically depressed diabetic patients. For the majority of depressed diabetic patients suffering from subthreshold depression no evaluated specific intervention concept exists. Since subthreshold depression often is associated with diabetes related distress a diabetes specific intervention was developed to support patients to increase their problem solving skills, modify their depressive cognitions and improve their coping with diabetes related distress. It consists of five sessions and is delivered as a group intervention.

This study is an efficacy trial. In this randomized trial the efficacy of this newly developed intervention is compared to a control condition consisting of five standard diabetes education lessons. The primary outcome variable is the reduction of depressive symptoms twelve months after the intervention. Secondary outcome variables are the quality of life, metabolic parameters, self-care behavior and other psychosocial aspects. Furthermore the possible covariation between change of depressive symptoms and inflammatory and immune markers will be analyzed.

Study Design

Study Type:
Interventional
Actual Enrollment :
214 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Development and Evaluation of a Diabetes-specific Cognitive Behavioural Treatment (DS-CBT) for Diabetic Patients With Subthreshold Depression
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Mar 1, 2012
Actual Study Completion Date :
May 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diabetes-Specific CBT (DS-CBT)

Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems

Behavioral: Diabetes-Specific CBT (DS-CBT)
5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement
Other Names:
  • Diabetes-Specific Cognitive-Behavioral Group Sessions
  • Active Comparator: Standard Diabetes Education

    Standard Diabetes Education Lessons will be given to quantify the unspecific antidepressive Effects of Participation in Group Sessions with social Contact and Acquisition of Knowledge.

    Behavioral: Standard Diabetes Education
    Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Other Names:
  • Educative Group Lesson and Discussion
  • Outcome Measures

    Primary Outcome Measures

    1. Depressive Symptoms (CES-D Score) [Baseline, 12 month FU]

      The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess depressive symptoms. The CES-D assesses the frequency of 20 typical symptoms of depression during the previous week on a 4-point Likert scale. Summing of the item scores estimates the total score with a range between 0 and 60 and higher scores indicating more severe depressive mood. Based on the measurement of depressive symptoms at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.

    Secondary Outcome Measures

    1. Quality of Life (EQ-5D TTO Score) [Baseline,12 month FU]

      The EuroQol Five Dimension Questionnaire (EQ-5D) was used to assess health-related quality of life (HRQOL). The EQ-5D assesses five dimensions of HRQOL using a 3-point scale. The item scores are weighted based on population data and used to calculate a standardised total score from 0 to 1 with higher scores indicating better HRQOL. Based on the measurement of HRQOL at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.

    2. Diabetes-specific Distress (PAID Score) [Baseline, 12 month FU]

      The Problem areas in Diabetes Scale (PAID) was used to assess diabetes-specific distress. The PAID assesses diabetes-specific distress using 20 items and a five-point Likert scale (0 - 4). Item scores are summed and transformed to a range from 0 - 100 with higher scores indicating higher distress. Based on the measurement of diabetes-specific distress at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.

    3. Diabetes Self-Care (SDSCA Score) [Baseline, 12 month FU]

      The Summary of Diabetes Self-Care Activities Measure (SDSCA) was used to assess diabetes self-care. The SDSCA assesses the number of days of the previous week (0 - 7) on which several specific self-care activities (appropriate diet, physical activity, self-monitoring of blood glucose, foot care) were performed. The item scores are summed and averaged to a total score from 0 to 7 with higher scores indicating better overall self-care. Based on the measurement of diabetes self-care at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.

    4. Diabetes Acceptance (AADQ Score) [Baseline, 12 month FU]

      The Acceptance and Action Diabetes Questionnaire (AADQ) was used to assessment of diabetes acceptance. Using 11 items on diabetes-related experiential avoidance behaviours and a 5-point Likert response scale (1 - 5), the AADQ estimates the overall level of diabetes acceptance. Item scores are summed to a total score between 11 and 55 with higehr scores indicating better acceptance. Based on the measurement of diabetes acceptance at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.

    5. Glycemic Control (HbA1c) [Baseline, 12 month FU]

      The HbA1c was used as measure of glycemic control. All blood samples were analysed in a central laboratory using the Bio-Rad II Turbo analyser; the measurement units were %-points. Based on the measurement at baseline and 12-month follow up, the difference of the HbA1c values between baseline and 12 month follow up was calculated.

    6. Inflammatory Marker IL-6 [Baseline, 12 month FU]

      The inflammatory marker Interleukin 6 (IL-6) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.

    7. Inflammatory Marker IL-1Ra [Baseline, 12 month FU]

      The inflammatory marker Interleukin 1 receptor antagonist (IL-1Ra) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.

    8. Inflammatory Marker Hs-CRP [Baseline, 12 month FU]

      The inflammatory marker high sensitivity C-reactive protein (hs-CRP) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.

    9. Health-care Costs: Health-care Utilisation [Baseline, 12 months-FU]

      Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.

    10. Health-care Costs: Non-productive Time [Baseline, 12 months-FU]

      Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.

    11. Health-care Costs: Medication Intake [Baseline, 12 months-FU]

      Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diabetes mellitus

    • Elevated depressive symptoms (regarding to CES-D)

    • Age >= 18 and <=70

    • Sufficient German language skills

    • Informed consent

    Exclusion Criteria:
    • Current MDD

    • Current schizophrenia/ psychotic disorder, eating disorder, bipolar disorder, addictive disorder, personality disorder

    • Current antidepressive medication

    • Current psychotherapy

    • Severe physical illness (i.e. cancer)

    • Being bedridden

    • Guardianship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Forschungsinstitut der Diabetes Akademie Mergentheim e. V. Bad Mergentheim Baden-Württemberg Germany 97980

    Sponsors and Collaborators

    • Forschungsinstitut der Diabetes Akademie Mergentheim
    • German Diabetes Center
    • University of Giessen
    • Heinrich-Heine University, Duesseldorf

    Investigators

    • Principal Investigator: Bernhard Kulzer, PhD, Forschungsinstitut der Diabetes Akademie Mergentheim e. V.
    • Principal Investigator: Norbert Hermanns, Prof., PhD, Forschungsinstitut der Diabetes Akademie Mergentheim e. V.
    • Study Director: Thomas J Haak, Prof., MD, Diabetes Zentrum Mergentheim; Forschungsinstitut der Diabetes Akademie Mergentheim e. V.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Norbert Hermanns, Prof. Dr., Forschungsinstitut der Diabetes Akademie Mergentheim
    ClinicalTrials.gov Identifier:
    NCT01009138
    Other Study ID Numbers:
    • FKZ 01GI0809
    First Posted:
    Nov 6, 2009
    Last Update Posted:
    Nov 26, 2015
    Last Verified:
    Oct 1, 2015

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Period Title: Overall Study
    STARTED 106 108
    COMPLETED 93 88
    NOT COMPLETED 13 20

    Baseline Characteristics

    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education Total
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy Total of all reporting groups
    Overall Participants 106 108 214
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    43
    (15)
    43
    (14)
    43
    (13)
    Sex: Female, Male (Count of Participants)
    Female
    60
    56.6%
    61
    56.5%
    121
    56.5%
    Male
    46
    43.4%
    47
    43.5%
    93
    43.5%
    Type 1 diabetes (participants) [Number]
    Number [participants]
    63
    59.4%
    78
    72.2%
    141
    65.9%
    Diabetes duration (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    14
    (10)
    14
    (11)
    14
    (11)
    HbA1c (%-points) (%-points) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [%-points]
    8.9
    (1.8)
    8.9
    (1.8)
    8.9
    (1.8)
    BMI (kg/m2) (kg/m2) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [kg/m2]
    30
    (8)
    28
    (6)
    29
    (7)

    Outcome Measures

    1. Primary Outcome
    Title Depressive Symptoms (CES-D Score)
    Description The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess depressive symptoms. The CES-D assesses the frequency of 20 typical symptoms of depression during the previous week on a 4-point Likert scale. Summing of the item scores estimates the total score with a range between 0 and 60 and higher scores indicating more severe depressive mood. Based on the measurement of depressive symptoms at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [Scores on a scale]
    -7.4
    (11.4)
    -2.7
    (11.7)
    2. Secondary Outcome
    Title Quality of Life (EQ-5D TTO Score)
    Description The EuroQol Five Dimension Questionnaire (EQ-5D) was used to assess health-related quality of life (HRQOL). The EQ-5D assesses five dimensions of HRQOL using a 3-point scale. The item scores are weighted based on population data and used to calculate a standardised total score from 0 to 1 with higher scores indicating better HRQOL. Based on the measurement of HRQOL at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.
    Time Frame Baseline,12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [Scores on a scale]
    -0.01
    (0.23)
    -0.01
    (0.25)
    3. Secondary Outcome
    Title Diabetes-specific Distress (PAID Score)
    Description The Problem areas in Diabetes Scale (PAID) was used to assess diabetes-specific distress. The PAID assesses diabetes-specific distress using 20 items and a five-point Likert scale (0 - 4). Item scores are summed and transformed to a range from 0 - 100 with higher scores indicating higher distress. Based on the measurement of diabetes-specific distress at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [Scores on a scale]
    -13.0
    (18.9)
    -4.2
    (16.9)
    4. Secondary Outcome
    Title Diabetes Self-Care (SDSCA Score)
    Description The Summary of Diabetes Self-Care Activities Measure (SDSCA) was used to assess diabetes self-care. The SDSCA assesses the number of days of the previous week (0 - 7) on which several specific self-care activities (appropriate diet, physical activity, self-monitoring of blood glucose, foot care) were performed. The item scores are summed and averaged to a total score from 0 to 7 with higher scores indicating better overall self-care. Based on the measurement of diabetes self-care at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [Scores on a scale]
    -0.1
    (1.1)
    0.0
    (1.0)
    5. Secondary Outcome
    Title Diabetes Acceptance (AADQ Score)
    Description The Acceptance and Action Diabetes Questionnaire (AADQ) was used to assessment of diabetes acceptance. Using 11 items on diabetes-related experiential avoidance behaviours and a 5-point Likert response scale (1 - 5), the AADQ estimates the overall level of diabetes acceptance. Item scores are summed to a total score between 11 and 55 with higehr scores indicating better acceptance. Based on the measurement of diabetes acceptance at baseline and 12-month follow up, the difference of the test scores between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [Scores on a scale]
    2.5
    (7.7)
    2.0
    (6.6)
    6. Secondary Outcome
    Title Glycemic Control (HbA1c)
    Description The HbA1c was used as measure of glycemic control. All blood samples were analysed in a central laboratory using the Bio-Rad II Turbo analyser; the measurement units were %-points. Based on the measurement at baseline and 12-month follow up, the difference of the HbA1c values between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [%-points]
    -0.5
    (2.0)
    -0.7
    (1.7)
    7. Secondary Outcome
    Title Inflammatory Marker IL-6
    Description The inflammatory marker Interleukin 6 (IL-6) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (95% Confidence Interval) [pg/ml]
    0.0
    0.1
    8. Secondary Outcome
    Title Inflammatory Marker IL-1Ra
    Description The inflammatory marker Interleukin 1 receptor antagonist (IL-1Ra) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (95% Confidence Interval) [pg/ml]
    -100.5
    -70.8
    9. Secondary Outcome
    Title Inflammatory Marker Hs-CRP
    Description The inflammatory marker high sensitivity C-reactive protein (hs-CRP) was assessed as measure of distress-related immune activity. The differences of the serum-concentrations between baseline and 12 month follow up were calculated.
    Time Frame Baseline, 12 month FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (95% Confidence Interval) [mg/dl]
    0.0
    0.0
    10. Secondary Outcome
    Title Health-care Costs: Health-care Utilisation
    Description Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 months-FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [number of medical appointment/half year]
    -2.2
    (15.4)
    -1.4
    (13.3)
    11. Secondary Outcome
    Title Health-care Costs: Non-productive Time
    Description Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 months-FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [number of days on sick leave/half year]
    -2.2
    (33.2)
    5.8
    (30.2)
    12. Secondary Outcome
    Title Health-care Costs: Medication Intake
    Description Several aspects of interest regarding diabetes-related health-care costs were assessed in order to evaluate potential reductions of health-care costs following the treatment. Measurement was performed using retrospective interview refering to the previous 6 months: The assessed aspects were 1.) the number of out-patient medical appointments as a measure of costs related to health-care utilisation, 2.) the number of days on sick leave as a measure of costs related to non-productive time and 3.) the number of daily taken prescription medications as a measure of costs related to medication intake. For each aspect, the difference of the numbers between baseline and 12 month follow up was calculated.
    Time Frame Baseline, 12 months-FU

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    Measure Participants 93 88
    Mean (Standard Deviation) [number of daily medications/half year]
    0.7
    (1.6)
    0.8
    (2.0)

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Arm/Group Description Cognitive Behavioral Intervention (Group) focusing on Diabetes-Specific Problems Diabetes-Specific CBT (DS-CBT): 5 Group Sessions with a duration of 90 Minutes each, including the following cognitive-behavioral Intervention Methods focusing on Diabetes Distress and Hassles: Problem Analysis and Definition Problem Solving Intervention Cognitive Restructuring Activation of personal and social Resources Goal Definition and Agreement Standard Diabetes Education Lessons with social Contact and Acquisition of Knowledge. Standard Diabetes Education: Standard Diabetes Education Lesson including Health Care and specific Topics (e. g. Blood Pressure) Social Aspects of Living with Diabetes Diabetes Complications Sports, Activities and Exercise Healthy and unhealthy Food, Vitamins, Cooking Recommendations and Recipes Foot Care: Exercises, Care and Control, Sensibility, Injuries, diabetic Neuropathy
    All Cause Mortality
    Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 11/106 (10.4%) 21/108 (19.4%)
    Gastrointestinal disorders
    Norwalk-Virus 3/106 (2.8%) 4/108 (3.7%)
    General disorders
    New diagnosis of diabetes long-term complication 1/106 (0.9%) 3/108 (2.8%)
    New diagnosis of cancer 2/106 (1.9%) 2/108 (1.9%)
    Death 0/106 (0%) 1/108 (0.9%)
    Metabolism and nutrition disorders
    Severe Hypoglycaemia 3/106 (2.8%) 7/108 (6.5%)
    Ketoacidosis 2/106 (1.9%) 4/108 (3.7%)
    Other (Not Including Serious) Adverse Events
    Diabetes-Specific CBT (DS-CBT) Standard Diabetes Education
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 28/106 (26.4%) 28/108 (25.9%)
    General disorders
    Nonsevere adverse event 28/106 (26.4%) 28/108 (25.9%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Bernhard Kulzer
    Organization Research Institute of the Diabetes Academy Mergentheim
    Phone +49 7931 ext 594151
    Email kulzer@diabetes-zentrum.de
    Responsible Party:
    Norbert Hermanns, Prof. Dr., Forschungsinstitut der Diabetes Akademie Mergentheim
    ClinicalTrials.gov Identifier:
    NCT01009138
    Other Study ID Numbers:
    • FKZ 01GI0809
    First Posted:
    Nov 6, 2009
    Last Update Posted:
    Nov 26, 2015
    Last Verified:
    Oct 1, 2015